Cladribine
(PTOAARAWEBMLNO-KVQBGUIXSA-N)
Structure
- SMILES
- OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2c1nc(Cl)nc2N
- Type(s)
- Approved; Investigational
- ATC code(s)
- L01BB04; L04AA40
- Molecular Formula:
- C10H12ClN5O3
- Molecular Weight:
- 285.687
- Log P:
- 0.2838
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 3
- TPSA:
- 119.31
- CAS Number(s):
- 4291-63-8
Synonym(s)
1.
Cladribine
2.
2-Chloro-2'-deoxyadenosine
3.
2-Chlorodeoxyadenosine
4.
2'-Deoxy-2-chloroadenosine
5.
Leustatin
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | White blood cell count decreased | FAERS: 17 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 2 | Thrombocytopenia | FAERS: 13 | CTD SIDER US FAERS | |
| 3 | Pancytopenia | FAERS: 12 | 16398735 | CTD SIDER US FAERS |
| 4 | Sepsis | FAERS: 12 | SIDER US FAERS | |
| 5 | MYELODYSPLASTIC SYNDROME | FAERS: 11 | SIDER US FAERS | |
| 6 | Febrile Neutropenia | FAERS: 10 | SIDER US FAERS | |
| 7 | Multiple sclerosis relapse | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Headache | FAERS: 8 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 9 | Incorrect route of drug administration | FAERS: 8 | US FAERS | |
| 10 | No adverse event | FAERS: 8 | US FAERS | |
| 11 | Leukopenia | FAERS: 7 | US FAERS | |
| 12 | Fatigue | FAERS: 6 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 13 | Infection | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 14 | Lymphopenia | FAERS: 6 | 7850921 | CTD SIDER US FAERS |
| 15 | Nausea | FAERS: 6 Canada Vigilance: 8 | 7850921 15654901 | CTD SIDER Canada Vigilance US FAERS |
| 16 | Neutropenia | FAERS: 6 Canada Vigilance: 1 | 7655003 7971251 15654901 | CTD SIDER Canada Vigilance US FAERS |
| 17 | Pneumonia | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 18 | Drug ineffective | FAERS: 5 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 19 | Erythema | FAERS: 5 | OFFSIDES SIDER US FAERS | |
| 20 | Incorrect drug administration rate | FAERS: 5 | US FAERS | |
| 21 | Bone marrow depression | FAERS: 4 | OFFSIDES US FAERS | |
| 22 | Disseminated Intravascular Coagulation | FAERS: 4 Canada Vigilance: 1 | 10792402 | CTD Canada Vigilance US FAERS |
| 23 | Lethargy | FAERS: 4 | SIDER US FAERS | |
| 24 | Lymphocyte count decreased | FAERS: 4 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 25 | Nasopharyngitis | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 26 | Accidental overdose | FAERS: 3 | OFFSIDES US FAERS | |
| 27 | Ascites | FAERS: 3 | OFFSIDES US FAERS | |
| 28 | Blood creatinine increased | FAERS: 3 | US FAERS | |
| 29 | Hypotension | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 30 | Lower respiratory tract infection | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Neutrophil count decreased | FAERS: 3 | OFFSIDES US FAERS | |
| 32 | Product use issue | FAERS: 3 | US FAERS | |
| 33 | Stomatitis | FAERS: 3 | US FAERS | |
| 34 | Vasculitis | FAERS: 3 | US FAERS | |
| 35 | Alanine Aminotransferase Increased | FAERS: 2 | OFFSIDES US FAERS | |
| 36 | Alopecia | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 37 | Anuria | FAERS: 2 | OFFSIDES US FAERS | |
| 38 | Aspergillosis | FAERS: 2 | US FAERS | |
| 39 | Basal cell carcinoma | FAERS: 2 | US FAERS | |
| 40 | Bronchopulmonary Aspergillosis | FAERS: 2 | US FAERS | |
| 41 | Colony stimulating factor therapy | FAERS: 2 | US FAERS | |
| 42 | Constipation | FAERS: 2 | SIDER US FAERS | |
| 43 | Diffuse Large B-Cell Lymphoma | FAERS: 2 | US FAERS | |
| 44 | Dizziness | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 45 | Ejection Fraction Decreased | FAERS: 2 | US FAERS | |
| 46 | Enteropathy-Associated T-Cell Lymphoma | FAERS: 2 | US FAERS | |
| 47 | Extravasation | FAERS: 2 | SIDER US FAERS | |
| 48 | Gastrointestinal inflammation | FAERS: 2 | US FAERS | |
| 49 | Glioblastoma | FAERS: 2 | US FAERS | |
| 50 | Hepatitis B | FAERS: 2 | OFFSIDES US FAERS | |
| 51 | Hypersensitivity | FAERS: 2 | SIDER US FAERS | |
| 52 | Injection Site Reaction | FAERS: 2 | SIDER US FAERS | |
| 53 | Lymphoma | FAERS: 2 | OFFSIDES US FAERS | |
| 54 | Malaise | FAERS: 2 | SIDER US FAERS | |
| 55 | Malignant neoplasm progression | FAERS: 2 | OFFSIDES US FAERS | |
| 56 | Mental impairment | FAERS: 2 | US FAERS | |
| 57 | Neutropenic sepsis | FAERS: 2 | US FAERS | |
| 58 | Pain | FAERS: 2 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 59 | Platelet Transfusion | FAERS: 2 | US FAERS | |
| 60 | Pneumonitis | FAERS: 2 | US FAERS | |
| 61 | Respiratory Failure | FAERS: 2 | OFFSIDES US FAERS | |
| 62 | Septic Shock | FAERS: 2 | SIDER US FAERS | |
| 63 | Tachycardia | FAERS: 2 | SIDER US FAERS | |
| 64 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 65 | Transaminases abnormal | FAERS: 2 | US FAERS | |
| 66 | Urinary tract infection | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 67 | Ventricular hypokinesia | FAERS: 2 | OFFSIDES US FAERS | |
| 68 | Weight decreased | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 69 | Abdominal Pain | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 70 | Actinic keratosis | FAERS: 1 | US FAERS | |
| 71 | Acute hepatitis C | FAERS: 1 | US FAERS | |
| 72 | Adverse event | FAERS: 1 | US FAERS | |
| 73 | Agranulocytosis | FAERS: 1 | 7850921 | CTD US FAERS |
| 74 | Anger | FAERS: 1 | US FAERS | |
| 75 | Aphonia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 76 | Arthralgia | FAERS: 1 | SIDER US FAERS | |
| 77 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 78 | Asthenopia | FAERS: 1 | US FAERS | |
| 79 | Autoscopy | FAERS: 1 | US FAERS | |
| 80 | Bladder Neoplasm | FAERS: 1 | US FAERS | |
| 81 | Blindness | FAERS: 1 | 7911736 | CTD US FAERS |
| 82 | Blood albumin decreased | FAERS: 1 | OFFSIDES US FAERS | |
| 83 | Blood albumin increased | FAERS: 1 | US FAERS | |
| 84 | Blood creatine phosphokinase increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 85 | Blood iron increased | FAERS: 1 | US FAERS | |
| 86 | Blood lactate dehydrogenase abnormal | FAERS: 1 | US FAERS | |
| 87 | Blood product transfusion dependent | FAERS: 1 | US FAERS | |
| 88 | Bone pain | FAERS: 1 | SIDER US FAERS | |
| 89 | Bronchospasm | FAERS: 1 | US FAERS | |
| 90 | Capillary Leak Syndrome | FAERS: 1 | US FAERS | |
| 91 | Chills | FAERS: 1 | SIDER US FAERS | |
| 92 | Cholelithiasis | FAERS: 1 | US FAERS | |
| 93 | Chronic sinusitis | FAERS: 1 | US FAERS | |
| 94 | Contraindicated product administered | FAERS: 1 | US FAERS | |
| 95 | Cystitis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 96 | Cytomegalovirus gastrointestinal infection | FAERS: 1 | US FAERS | |
| 97 | Deafness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 98 | Depressed mood | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 99 | Device deployment issue | FAERS: 1 | US FAERS | |
| 100 | Device related infection | FAERS: 1 | US FAERS | |
| 101 | Diabetes Insipidus | FAERS: 1 | US FAERS | |
| 102 | Disorientation | FAERS: 1 | SIDER US FAERS | |
| 103 | Diverticular perforation | FAERS: 1 | OFFSIDES US FAERS | |
| 104 | Epilepsy | FAERS: 1 | SIDER US FAERS | |
| 105 | Epstein-Barr virus antibody positive | FAERS: 1 | US FAERS | |
| 106 | Epstein-Barr virus associated lymphoma | FAERS: 1 | US FAERS | |
| 107 | Erythema Multiforme | FAERS: 1 | 10792402 | CTD OFFSIDES SIDER US FAERS |
| 108 | External ear pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 109 | Feeling abnormal | FAERS: 1 | SIDER US FAERS | |
| 110 | Full blood count decreased | FAERS: 1 | US FAERS | |
| 111 | Gamma-Glutamyltransferase Increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 112 | Gastrointestinal viral infection | FAERS: 1 | US FAERS | |
| 113 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 114 | Haematotoxicity | FAERS: 1 | US FAERS | |
| 115 | Hepatomegaly | FAERS: 1 | US FAERS | |
| 116 | Hepatotoxicity | FAERS: 1 | US FAERS | |
| 117 | Hydronephrosis | FAERS: 1 | US FAERS | |
| 118 | Hypereosinophilic syndrome | FAERS: 1 | US FAERS | |
| 119 | Hypertransaminasaemia | FAERS: 1 | OFFSIDES US FAERS | |
| 120 | Hypoperfusion | FAERS: 1 | US FAERS | |
| 121 | Hypophagia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Hypopituitarism | FAERS: 1 | US FAERS | |
| 123 | Hypoxia | FAERS: 1 | US FAERS | |
| 124 | Immunosuppression | FAERS: 1 | US FAERS | |
| 125 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 126 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 127 | Infection reactivation | FAERS: 1 | US FAERS | |
| 128 | Influenza | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 129 | Injection site inflammation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 130 | Listeriosis | FAERS: 1 | US FAERS | |
| 131 | Lobar Pneumonia | FAERS: 1 | US FAERS | |
| 132 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 133 | Lymphocyte percentage decreased | FAERS: 1 | US FAERS | |
| 134 | Maternal exposure timing unspecified | FAERS: 1 | US FAERS | |
| 135 | Mediastinal effusion | FAERS: 1 | US FAERS | |
| 136 | Menorrhagia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 137 | Metastasis | FAERS: 1 | US FAERS | |
| 138 | Metastatic Renal Cell Carcinoma | FAERS: 1 | US FAERS | |
| 139 | Multiple Sclerosis | FAERS: 1 Canada Vigilance: 1 | 12898844 | CTD Canada Vigilance US FAERS |
| 140 | Musculoskeletal discomfort | FAERS: 1 | SIDER US FAERS | |
| 141 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 142 | Myalgia | FAERS: 1 | SIDER US FAERS | |
| 143 | Myasthenia Gravis | FAERS: 1 | US FAERS | |
| 144 | Nerve injury | FAERS: 1 | US FAERS | |
| 145 | Non-Hodgkin's lymphoma refractory | FAERS: 1 | OFFSIDES US FAERS | |
| 146 | Orchitis | FAERS: 1 | US FAERS | |
| 147 | Oropharyngeal swelling | FAERS: 1 | US FAERS | |
| 148 | Ovarian failure | FAERS: 1 | US FAERS | |
| 149 | Palpitations | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 150 | Pelvic mass | FAERS: 1 | US FAERS | |
| 151 | Pemphigus | FAERS: 1 | US FAERS | |
| 152 | Performance status decreased | FAERS: 1 | US FAERS | |
| 153 | Pharmaceutical product complaint | FAERS: 1 | US FAERS | |
| 154 | Plasmapheresis | FAERS: 1 | US FAERS | |
| 155 | Pneumococcal sepsis | FAERS: 1 | US FAERS | |
| 156 | Poor quality sleep | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 157 | Portal Vein Thrombosis | FAERS: 1 | US FAERS | |
| 158 | Presyncope | FAERS: 1 | US FAERS | |
| 159 | Pulmonary Embolism | FAERS: 1 | SIDER US FAERS | |
| 160 | Pyelonephritis | FAERS: 1 | US FAERS | |
| 161 | Renal tubular disorder | FAERS: 1 | US FAERS | |
| 162 | Respiratory distress | FAERS: 1 | US FAERS | |
| 163 | Serology positive | FAERS: 1 | US FAERS | |
| 164 | Sinusitis | FAERS: 1 | US FAERS | |
| 165 | Skin Papilloma | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 166 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 167 | Staphylococcal impetigo | FAERS: 1 | US FAERS | |
| 168 | Syncope | FAERS: 1 | US FAERS | |
| 169 | Syphilis | FAERS: 1 | US FAERS | |
| 170 | Therapeutic product effect incomplete | FAERS: 1 | US FAERS | |
| 171 | Therapy non-responder | FAERS: 1 | OFFSIDES US FAERS | |
| 172 | Throat cancer | FAERS: 1 | US FAERS | |
| 173 | Tuberculosis | FAERS: 1 | US FAERS | |
| 174 | Tumour haemorrhage | FAERS: 1 | US FAERS | |
| 175 | Vertigo | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 176 | Vomiting | FAERS: 1 Canada Vigilance: 1 | 7850921 15654901 | CTD SIDER Canada Vigilance US FAERS |
| 177 | jaundice | FAERS: 1 | US FAERS | |
| 178 | Abdominal discomfort | Canada Vigilance: 4 | Canada Vigilance SIDER | |
| 179 | Abnormalities, Drug-Induced | 12115775 | CTD | |
| 180 | Administration site reaction | SIDER | ||
| 181 | Ageusia | Canada Vigilance: 1 | Canada Vigilance | |
| 182 | Altered state of consciousness | SIDER | ||
| 183 | Amyloidosis | SIDER | ||
| 184 | Anemia, Hemolytic | 16398735 | CTD | |
| 185 | Anemia | 7655003 7850921 | CTD | |
| 186 | Anorexia | 7850921 | CTD OFFSIDES SIDER | |
| 187 | Anosmia | Canada Vigilance: 1 | Canada Vigilance | |
| 188 | Anoxic Encephalopathy | OFFSIDES | ||
| 189 | Anxiety | Canada Vigilance: 2 | Canada Vigilance SIDER | |
| 190 | Arthritis | SIDER | ||
| 191 | Asthenia | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 192 | Ataxia | SIDER | ||
| 193 | Atrial Fibrillation | SIDER | ||
| 194 | Atrioventricular Block | 15561348 | CTD | |
| 195 | Automatism | OFFSIDES | ||
| 196 | Back Pain | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 197 | Blepharitis | SIDER | ||
| 198 | Blood alkaline phosphatase increased | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 199 | Blood and lymphatic system disorders | SIDER | ||
| 200 | Blood chloride decreased | OFFSIDES | ||
| 201 | Blood lactate dehydrogenase increased | OFFSIDES | ||
| 202 | Blood urea increased | OFFSIDES | ||
| 203 | Bone Marrow Diseases | 7911736 | CTD | |
| 204 | Brain Death | OFFSIDES | ||
| 205 | Bronchitis | Canada Vigilance: 1 | Canada Vigilance | |
| 206 | Bronchoalveolar Lavage | OFFSIDES | ||
| 207 | Bronchopneumonia | OFFSIDES | ||
| 208 | Bulbar palsy | OFFSIDES | ||
| 209 | Burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 210 | Bursitis | Canada Vigilance: 1 | Canada Vigilance | |
| 211 | CD4 Lymphocytes Decreased | OFFSIDES | ||
| 212 | Cachexia | SIDER | ||
| 213 | Catheter site cellulitis | SIDER | ||
| 214 | Cellulitis | SIDER | ||
| 215 | Cerebrovascular accident | SIDER | ||
| 216 | Chest Pain | SIDER | ||
| 217 | Chimerism | OFFSIDES | ||
| 218 | Cholecystitis | SIDER | ||
| 219 | Circumstance or information capable of leading to medication error | OFFSIDES | ||
| 220 | Cold sweat | OFFSIDES | ||
| 221 | Conjunctival deposit | OFFSIDES | ||
| 222 | Conjunctivitis | SIDER | ||
| 223 | Culture negative | SIDER | ||
| 224 | Cyst | SIDER | ||
| 225 | Demyelinating Diseases | 7949097 | CTD | |
| 226 | Demyelination | OFFSIDES | ||
| 227 | Depressed Level of Consciousness | SIDER | ||
| 228 | Dermatitis | SIDER | ||
| 229 | Differential white blood cell count abnormal | OFFSIDES | ||
| 230 | Discomfort | SIDER | ||
| 231 | Disease Progression | OFFSIDES | ||
| 232 | Disease complication | OFFSIDES | ||
| 233 | Disease recurrence | OFFSIDES | ||
| 234 | Dyspnea | 10792402 | CTD | |
| 235 | Ecchymosis | SIDER | ||
| 236 | Enteritis | OFFSIDES | ||
| 237 | Eosinophilia | SIDER | ||
| 238 | Epistaxis | SIDER | ||
| 239 | Eructation | Canada Vigilance: 1 | Canada Vigilance | |
| 240 | Fatty Liver | OFFSIDES | ||
| 241 | Fetal Resorption | 12115775 | CTD | |
| 242 | Fever | CTD | ||
| 243 | Flatulence | SIDER | ||
| 244 | Flushing | Canada Vigilance: 1 | Canada Vigilance | |
| 245 | Gangrene | Canada Vigilance: 1 | Canada Vigilance | |
| 246 | Gastrointestinal Pain | SIDER | ||
| 247 | Graft dysfunction | OFFSIDES | ||
| 248 | Guillain-Barre Syndrome | 11342351 | CTD | |
| 249 | Heart failure | 9322907 | CTD | |
| 250 | Hernia | 12115775 | CTD | |
| 251 | Herpes NOS | SIDER | ||
| 252 | Hypereosinophilia | SIDER | ||
| 253 | Hypersomnia | Canada Vigilance: 2 | Canada Vigilance | |
| 254 | Ileus | SIDER | ||
| 255 | Incontinence | OFFSIDES | ||
| 256 | Infarction | SIDER | ||
| 257 | Infestation | SIDER | ||
| 258 | Inflammation | SIDER | ||
| 259 | Infusion site reaction | SIDER | ||
| 260 | Leukopenia neonatal | OFFSIDES | ||
| 261 | Leukostasis | OFFSIDES | ||
| 262 | Lung Neoplasms | 21720004 | CTD | |
| 263 | Lymphoma, T-Cell, Cutaneous | 7948311 | CTD | |
| 264 | Lymphoplasmacytoid lymphoma/immunocytoma | OFFSIDES | ||
| 265 | Malnutrition | SIDER | ||
| 266 | Metabolic acidosis | SIDER | ||
| 267 | Microphthalmos | 12115775 | CTD | |
| 268 | Mononeuritis | OFFSIDES | ||
| 269 | Muscle Spasticity | Canada Vigilance: 1 | Canada Vigilance | |
| 270 | Musculoskeletal Pain | SIDER | ||
| 271 | Myelitis | OFFSIDES | ||
| 272 | Myelodysplasia | OFFSIDES | ||
| 273 | Myelosuppression | SIDER | ||
| 274 | Necrosis | 9619762 | CTD | |
| 275 | Nephrolithiasis | Canada Vigilance: 2 | Canada Vigilance | |
| 276 | Neuritis | SIDER | ||
| 277 | Neutropenic colitis | OFFSIDES | ||
| 278 | Optic Atrophy | OFFSIDES | ||
| 279 | Optic Neuritis | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 280 | Oral candidiasis | SIDER | ||
| 281 | Oral pain | Canada Vigilance: 1 | Canada Vigilance | |
| 282 | Oropharyngeal pain | Canada Vigilance: 1 | Canada Vigilance | |
| 283 | Pain of skin | SIDER | ||
| 284 | Paraparesis | OFFSIDES SIDER | ||
| 285 | Paraplegia | OFFSIDES | ||
| 286 | Pericarditis | Canada Vigilance: 1 | Canada Vigilance | |
| 287 | Peripheral Nervous System Diseases | 7949097 8726418 | CTD | |
| 288 | Peripheral motor neuropathy | SIDER | ||
| 289 | Petechiae | SIDER | ||
| 290 | Pharyngitis | SIDER | ||
| 291 | Phlebitis | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 292 | Pneumocystis jiroveci pneumonia | OFFSIDES | ||
| 293 | Polyneuropathy | SIDER | ||
| 294 | Poor quality product administered | Canada Vigilance: 1 | Canada Vigilance | |
| 295 | Primary Myelofibrosis | 15654901 | CTD | |
| 296 | Product storage error | Canada Vigilance: 1 | Canada Vigilance | |
| 297 | Productive Cough | Canada Vigilance: 2 | Canada Vigilance | |
| 298 | Protein total decreased | OFFSIDES | ||
| 299 | Pruritus | SIDER | ||
| 300 | Pulmonary Fibrosis | SIDER | ||
| 301 | Purpura | SIDER | ||
| 302 | Quadriparesis | SIDER | ||
| 303 | Rales | SIDER | ||
| 304 | Rash erythematous | SIDER | ||
| 305 | Redness | SIDER | ||
| 306 | Reticulocyte count increased | OFFSIDES | ||
| 307 | Rhabdomyolysis | OFFSIDES | ||
| 308 | Septicemia | SIDER | ||
| 309 | Somnolence | SIDER | ||
| 310 | Stem cell transplant | OFFSIDES | ||
| 311 | Stevens-Johnson Syndrome | 25811541 | CTD SIDER | |
| 312 | Stress | Canada Vigilance: 1 | Canada Vigilance | |
| 313 | Swelling | SIDER | ||
| 314 | Systemic Vasculitis | 12181031 | CTD | |
| 315 | T-Lymphocytopenia | 9684936 | CTD | |
| 316 | Thermal burn | Canada Vigilance: 1 | Canada Vigilance | |
| 317 | Thrombosis | SIDER | ||
| 318 | Tooth Loss | Canada Vigilance: 1 | Canada Vigilance | |
| 319 | Toxic Epidermal Necrolysis | SIDER | ||
| 320 | Transaminases increased | OFFSIDES | ||
| 321 | Treatment related secondary malignancy | OFFSIDES | ||
| 322 | Troponin increased | OFFSIDES | ||
| 323 | Urinary tract infection enterococcal | OFFSIDES | ||
| 324 | Urticaria | SIDER | ||
| 325 | Vascular purpura | SIDER | ||
| 326 | Vasospasm | Canada Vigilance: 1 | Canada Vigilance | |
| 327 | Visual Impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 328 | Waldenstrom Macroglobulinemia | 7948311 10721776 16432856 | CTD | |
| 329 | Wheezing | SIDER | ||
| 330 | nervous system disorder | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.